Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial.

Talley NJ, Kellow JE, Boyce P, Tennant C, Huskic S, Jones M.

Dig Dis Sci. 2008 Jan;53(1):108-15. Epub 2007 May 15.

PMID:
17503182
2.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
4.

Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.

Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):435-44.

5.
6.

A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.

Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ.

Am J Gastroenterol. 2010 Jan;105(1):170-7. doi: 10.1038/ajg.2009.577. Epub 2009 Oct 6.

PMID:
19809408
7.

Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents.

Bahar RJ, Collins BS, Steinmetz B, Ament ME.

J Pediatr. 2008 May;152(5):685-9. doi: 10.1016/j.jpeds.2007.10.012. Epub 2008 Feb 20.

PMID:
18410774
8.

A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.

Krause R, Ameen V, Gordon SH, West M, Heath AT, Perschy T, Carter EG.

Am J Gastroenterol. 2007 Aug;102(8):1709-19. Epub 2007 May 17.

PMID:
17509028
9.

Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.

Leung WK, Wu JC, Liang SM, Chan LS, Chan FK, Xie H, Fung SS, Hui AJ, Wong VW, Che CT, Sung JJ.

Am J Gastroenterol. 2006 Jul;101(7):1574-80.

PMID:
16863563
10.

Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.

Mangel AW, Bornstein JD, Hamm LR, Buda J, Wang J, Irish W, Urso D.

Aliment Pharmacol Ther. 2008 Jul;28(2):239-49. doi: 10.1111/j.1365-2036.2008.03730.x. Epub 2008 May 7.

11.

Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial.

Brinkhaus B, Hentschel C, Von Keudell C, Schindler G, Lindner M, Stützer H, Kohnen R, Willich SN, Lehmacher W, Hahn EG.

Scand J Gastroenterol. 2005 Aug;40(8):936-43.

PMID:
16173134
12.

Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.

Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA.

Am J Gastroenterol. 2008 May;103(5):1217-25. doi: 10.1111/j.1572-0241.2008.01808.x.

13.

Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.

Leventer SM, Raudibaugh K, Frissora CL, Kassem N, Keogh JC, Phillips J, Mangel AW.

Aliment Pharmacol Ther. 2008 Jan 15;27(2):197-206. Epub 2007 Oct 31.

14.

Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.

Han C, Masand PS, Krulewicz S, Peindl K, Mannelli P, Varia IM, Pae CU, Patkar AA.

J Clin Pharm Ther. 2009 Feb;34(1):79-88. doi: 10.1111/j.1365-2710.2008.00975.x.

PMID:
19125906
15.

A randomized controlled trial of imipramine in patients with irritable bowel syndrome.

Abdul-Baki H, El Hajj II, Elzahabi L, Azar C, Aoun E, Skoury A, Chaar H, Sharara AI.

World J Gastroenterol. 2009 Aug 7;15(29):3636-42.

16.

An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients.

Theobald DE, Kirsh KL, Holtsclaw E, Donaghy K, Passik SD.

Palliat Support Care. 2003 Mar;1(1):71-7.

PMID:
16594290
18.

Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.

Chang FY, Lu CL, Chen CY, Luo JC.

J Gastroenterol Hepatol. 2007 Dec;22(12):2266-72. Epub 2007 Jun 7.

PMID:
17559369
19.

Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.

Clavé P, Acalovschi M, Triantafillidis JK, Uspensky YP, Kalayci C, Shee V, Tack J; OBIS Study Investigators.

Aliment Pharmacol Ther. 2011 Aug;34(4):432-42. doi: 10.1111/j.1365-2036.2011.04730.x. Epub 2011 Jun 16.

20.

Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial.

Pace F, Maurano A, Ciacci C, Savarino V, Attili A, Iaquinto G, Magni E, Porro GB.

Eur Rev Med Pharmacol Sci. 2010 Mar;14(3):155-62.

PMID:
20391952

Supplemental Content

Support Center